Modern ophthalmology clinics face increasing patient volumes while specialist resources remain limited. Efficiently identifying patients requiring urgent attention has become an important challenge for hospitals worldwide. We are pleased to announce the start of a pilot deployment of EyeCheckup AI at Ankara Etlik City Hospital, where the system will support patient triage during routine ophthalmology

The nationwide deployment of EyeCheckup AI continues to expand, bringing AI-assisted diabetic retinopathy screening to additional hospitals and regions across Turkey.

Following the successful launch of the national screening initiative, deployment is now underway in multiple cities, demonstrating the scalability of AI-powered retinal screening in routine healthcare.

We are pleased to announce the launch of a nationwide diabetic retinopathy screening program in Turkey powered by EyeCheckup AI. The program marks an important milestone in bringing artificial intelligence into routine clinical practice at national scale.

We are proud to announce that EyeCheckup, our AI-powered retinal diagnostic platform, has been featured in a peer-reviewed study published in The Lancet Digital Health—one of the world’s leading journals in digital medicine. The article presents a new, independent evaluation platform designed to objectively assess the real-world performance of commercial artificial intelligence systems used for

We’re excited to share that EyeCheckup—our AI-powered retinal diagnostic system—has been featured in a peer-reviewed clinical study published in Nature Eye! The article “Head to head comparison of diagnostic performance of three non-mydriatic cameras for diabetic retinopathy screening with artificial intelligence” highlights EyeCheckup’s real-world performance in detecting sight-threatening retinal disease. Nature In this landmark study

EyeCheckup was chosen as one of the 20 startups selected from all European Union countries. We will present as finalists in front of more than 30 thousand people at the Wolves Summit conference. As a result, 10 startups selected will be accepted to the European Union acceleration program and receive a grant worth 100,000 Euros.

EyeCheckup is pleased to announce that we will be available to screen for diabetic retinopathy at the 2023 British Association of Retinal Screeners (BARS) Annual Conference 2023 in the United Kingdom. EyeCheckup AI-supported system is able to detect signs of diabetic retinopathy with best in class accuracy , enabling early diagnosis and treatment and helping to prevent

EyeCheckup Invited to Cambridge Lifesciences Cluster!As a finalist of Cambridge Life Sciences Market Access Programme, EyeCheckup have been invited the Cambridge Life Sciences Sector, Europe’s most productive life sciences cluster by Locate Cambridge. We plan to leverage this opportunity to continue our path towards excellence in our product through Cambridge’s state of the art research and development capabilities in relevance to